Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: A randomized placebo-controlled trial (END-HF)

Journal of Cardiovascular Translational Research

Volumn 7, Issue 6, 2014, Pages 545-552

  Santoso, Teguh ^a   Siu, Ching Wah ^b   Irawan, Cosphiadi ^a   Chan, Wing Sze ^b   Alwi, Idrus ^a   Yiu, Kai Hang ^b   Aziz, Auda ^c   Kwong, Yok Lam ^b   Tse, Hung Fat ^b  

^a CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Dharmais Cancer Hospital National Cancer Center   (Indonesia)

Author keywords

Bone marrow cells; Heart failure; Ischemic cardiomyopathy

Indexed keywords

PLACEBO;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW MONONUCLEAR CELL TRANSPLANTATION; CARDIOVASCULAR MAGNETIC RESONANCE; CELL TRANSPLANTATION; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; ENDOCARDIUM; EXERCISE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MALE; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; AUTOGRAFT; BONE MARROW TRANSPLANTATION; COMPLICATION; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; INJECTION; MYOCARDIAL ISCHEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY;

ANGINA;

AUTOGRAFTS; BONE MARROW TRANSPLANTATION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INJECTIONS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84906790563     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-014-9580-6     Document Type: Article

References (30)

1. Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., Franco, S., Fullerton, H. J., Gillespie, C., Hailpern, S. M., Heit, J. A., Howard, V. J., Huffman, M. D., Kissela, B. M., Kittner, S. J., Lackland, D. T., Lichtman, J. H., Lisabeth, L. D., Magid, D., Marcus, G. M., Marelli, A., Matchar, D. B., McGuire, D. K., Mohler, E. R., Moy, C. S., Mussolino, M. E., Nichol, G., Paynter, N. P., Schreiner, P. J., Sorlie, P. D., Stein, J., Turan, T. N., Virani, S. S., Wong, N. D., Woo, D., & Turner, M. B. (2013). American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation, 127, 143-152.
2. Blecker, S., Paul, M., Taksler, G., Ogedegbe, G., & Katz, S. (2013). Heart failure associated hospitalizations in the United States. Journal of the American College of Cardiology, 61, 1259-1267.
3. McMurray, J. J. (2010). Systolic heart failure. New England Journal of Medicine, 362, 228-238.
4. Siu, C. W., & Tse, H. F. (2012). Cardiac regeneration: messages from CADUCEUS. Lancet, 379, 870-871.
5. Deutsch, M. A., Sturzu, A., & Wu, S. M. (2013). At a crossroad: cell therapy for cardiac repair. Circulation Research, 112, 884-890.
6. Perin, E. C., Dohmann, H. F., Borojevic, R., Silva, S. A., Sousa, A. L., Mesquita, C. T., Rossi, M. I., Carvalho, A. C., Dutra, H. S., Dohmann, H. J., Silva, G. V., Belém, L., Vivacqua, R., Rangel, F. O., Esporcatte, R., Geng, Y. J., Vaughn, W. K., Assad, J. A., Mesquita, E. T., & Willerson, J. T. (2003). Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation, 107, 2294-2302. (Pubitemid 36578498)
7. Perin, E. C., Dohmann, H. F., Borojevic, R., Silva, S. A., Sousa, A. L., Silva, G. V., Mesquita, C. T., Belém, L., Vaughn, W. K., Rangel, F. O., Assad, J. A., Carvalho, A. C., Branco, R. V., Rossi, M. I., Dohmann, H. J., &Willerson, J. T. (2004). Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation, 110(11 Suppl 1), II213-II218. (Pubitemid 39263725)
8. Fuchs, S., Kornowski, R., Weisz, G., Satler, L. F., Smits, P. C., Okubagzi, P., Baffour, R., Aggarwal, A., Weissman, N. J., Cerqueira, M., Waksman, R., Serrruys, P., Battler, A., Moses, J. W., Leon, M. B., & Epstein, S. E. (2006). Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. American Journal of Cardiology, 97, 823-829.
9. Losordo, D. W., Schatz, R. A., White, C. J., Udelson, J. E., Veereshwarayya, V., Durgin, M., Poh, K. K., Weinstein, R., Kearney, M., Chaudhry, M., Burg, A., Eaton, L., Heyd, L., Thorne, T., Shturman, L., Hoffmeister, P., Story, K., Zak, V., Dowling, D., Traverse, J. H., Olson, R. E., Flanagan, J., Sodano, D., Murayama, T., Kawamoto, A., Kusano, K. F., Wollins, J., Welt, F., Shah, P., Soukas, P., Asahara, T., & Henry, T. D. (2007). Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation, 115, 3165-3172. (Pubitemid 47018140)
10. Tse, H. F., Thambar, S., Kwong, Y. L., Rowlings, P., Bellamy, G., McCrohon, J., Thomas, P., Bastian, B., Chan, J. K., Lo, G., Ho, C. L., Chan, W. S., Kwong, R. Y., Parker, A., Hauser, T. H., Chan, J., Fong, D. Y., & Lau, C. P. (2007). Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). European Heart Journal, 28, 2998-3005. (Pubitemid 350262782)
11. van Ramshorst, J., Bax, J. J., Beeres, S. L., Dibbets-Schneider, P., Roes, S. D., Stokkel, M. P., de Roos, A., Fibbe, W. E., Zwaginga, J. J., Boersma, E., Schalij, M. J., & Atsma, D. E. (2009). Intramyocardial bone marrow cell injection for chronic myocardial ischemia. JAMA, 301, 1997-2004.
12. Perin, E. C., Silva, G. V., Henry, T. D., Cabreira-Hansen, M. G., Moore, W. H., Coulter, S. A., Herlihy, J. P., Fernandes, M. R., Cheong, B. Y., Flamm, S. D., Traverse, J. H., Zheng, Y., Smith, D., Shaw, S., Westbrook, L., Olson, R., Patel, D., Gahremanpour, A., Canales, J., Vaughn, W. K., & Willerson, J. T. (2011). A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). American Heart Journal, 161, 1078-1087.
13. Losordo, D. W., Henry, T. D., Davidson, C., Sup Lee, J., Costa, M. A., Bass, T., Mendelsohn, F., Fortuin, F. D., Pepine, C. J., Traverse, J. H., Amrani, D., Ewenstein, B. M., Riedel, N., Story, K., Barker, K., Povsic, T. J., Harrington, R. A., & Schatz, R. A. (2011). ACT34-CMI Investigators. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circulation Research, 109, 428-436.
14. Perin, E. C., Willerson, J. T., Pepine, C. J., Henry, T. D., Ellis, S. G., Zhao, D. X., Silva, G. V., Lai, D., Thomas, J. D., Kronenberg, M. W., Martin, A. D., Anderson, R. D., Traverse, J. H., Penn, M. S., Anwaruddin, S., Hatzopoulos, A. K., Gee, A. P., Taylor, D. A., Cogle, C. R., Smith, D., Westbrook, L., Chen, J., Handberg, E., Olson, R. E., Geither, C., Bowman, S., Francescon, J., Baraniuk, S., Piller, L. B., Simpson, L. M., Loghin, C., Aguilar, D., Richman, S., Zierold, C., Bettencourt, J., Sayre, S. L., Vojvodic, R. W., Skarlatos, S. I., Gordon, D. J., Ebert, R. F., Kwak, M., Moyé, L. A., Simari, R. D., & Cardiovascular Cell Therapy Research Network (CCTRN). (2012). Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRNtrial. JAMA, 307, 1717-1726.
15. Grothues, F., Smith, G. C., Moon, J. C., Bellenger, N. G., Collins, P., Klein, H. U., & Pennell, D. J. (2002). Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. American Journal of Cardiology, 90, 29-34. (Pubitemid 34671198)
16. Kim, R. J., Wu, E., Rafael, A., Chen, E. L., Parker, M. A., Simonetti, O., Klocke, F. J., Bonow, R. O., & Judd, R. M. (2000). The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. New England Journal of Medicine, 343, 1445-1453.
17. Chan, C. W., Kwong, Y. L., Kwong, R. Y., Lau, C. P., & Tse, H. F. (2010). Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease. Journal of Cardiovascular Magnetic Resonance, 12, 6.
18. Santoso, T., Siu, C. W., Irawan, C., Chan, C. S., Alwi, I., Yiu, K. H., Azis, A., Kwong, Y. L., Tse, H. F. (2013). A randomized placebo controlled trial of endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure (END-HF). European Heart Journal, 34(suppl 1). doi:10.1093/eurheartj/eht309.3554.
19. Tse, H. F., Wong, K. K., Siu, C. W., Zhang, X. H., Ho, W. Y., & Lau, C. P. (2009). Upgrading pacemaker patients with right ventricular apical pacing to right ventricular septal pacing improves left ventricular performance and functional capacity. Journal of Cardiovascular Electrophysiology, 20, 901-905.
20. Laflamme, M. A., & Murry, C. E. (2011). Heart regeneration. Nature, 473, 326-335.
21. Hofmann, M., Wollert, K. C., Meyer, G. P., Menke, A., Arseniev, L., Hertenstein, B., Ganser, A., Knapp, W. H., & Drexler, H. (2005). Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation, 111, 2198-2202. (Pubitemid 40632435)
22. Liao, R., Pfister, O., Jain, M., & Mouquet, F. (2007). The bone marrow - cardiac axis of myocardial regeneration. Progress in Cardiovascular Diseases, 50, 18-30. (Pubitemid 47049720)
23. Yiu, K. H., & Tse, H. F. (2014). Specific role of impaired glucose metabolism and diabetes mellitus in endothelial progenitor cell characteristics and function. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1136-1143.
24. Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H., Zeiher, A. M., & Dimmeler, S. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation Research, 89, E1-E7.
25. Lai, W. H., Ho, J. C., Chan, Y. C., Ng, J. H., Au, K. W., Wong, L. Y., Siu, C. W., & Tse, H. F. (2013). Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells. PLoS One, 8, e57876.
26. Poole, J. C., & Quyyumi, A. A. (2013). Progenitor cell therapy to treat acute myocardial infarction: the promise of high-dose autologous CD34(+) bone marrow mononuclear cells. Stem Cells International.
27. Williams, A. R., & Hare, J. M. (2011). Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circulation Research, 109, 923 - 940.
28. Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y., Tracy, M., Ghersin, E., Johnston, P. V., Brinker, J. A., Breton, E., Davis-Sproul, J., Schulman, I. H., Byrnes, J., Mendizabal, A. M., Lowery, M. H., Rouy, D., Altman, P., Wong Po Foo, C., Ruiz, P., Amador, A., Da Silva, J., McNiece, I. K., & Heldman, A. W. (2012). Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA, 308, 2369-2379.
29. Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., El Nakadi, B., Banovic, M., Beleslin, B., Vrolix, M., Legrand, V., Vrints, C., Vanoverschelde, J. L., Crespo-Diaz, R., Homsy, C., Tendera, M., Waldman, S., Wijns, W., & Terzic, A. (2013). Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. Journal of the American College of Cardiology, 61, 2329-2338.
30. Williams, A. R., Hatzistergos, K. E., Addicott, B., McCall, F., Carvalho, D., Suncion, V., Morales, A. R., Da Silva, J., Sussman, M. A., Heldman, A. W., & Hare, J. M. (2013). Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation, 127, 213-223.